Cumberland Pharmaceuticals Inc. (CPIX) Reports Profitable Fourth Quarter 2009
Cumberland Pharmaceuticals Inc. reported net income of $3.1 million, or $0.17 per diluted share, for the year ending 12/31/2009. The company earned $4.8 million, or $0.29 per diluted share, in 2008. Cumberland Pharmaceuticals Inc. reported an increase in revenues on a year over year basis. The company had revenues of $43.5 million in 2009, up from $35.0 million in 2008. Cumberland Pharmaceuticals Inc. strengthened its balance sheet in 2009. The company reported a cash balance of $78.7 million in 2009, compared to $11.8 million in 2008. A.J. Kazimi, the CEO of Cumberland Pharmaceuticals Inc., said, “The approval and launch of…